Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-22,104
Closed -$671K 999
2025
Q3
$671K Sell
22,104
-1,457
-6% -$44.2K 0.1% 377
2025
Q2
$739K Sell
23,561
-4,418
-16% -$146K 0.12% 302
2025
Q1
$1.07M Buy
+27,979
New +$1.19M 0.17% 180
2023
Q4
Sell
-8,049
Closed -$424K 801
2023
Q3
$424K Buy
8,049
+2,151
+36% +$125K 0.13% 320
2023
Q2
$378K Buy
+5,898
New +$336K 0.11% 363
2019
Q4
Sell
-4,492
Closed -$225K 426
2019
Q3
$225K Buy
+4,492
New +$212K 0.2% 264
2017
Q4
Sell
-10,807
Closed -$775K 724
2017
Q3
$775K Sell
10,807
-1,220
-10% -$84.9K 0.22% 141
2017
Q2
$815K Buy
12,027
+8,309
+223% +$567K 0.28% 83
2017
Q1
$251K Buy
+3,718
New +$248K 0.1% 433
2016
Q3
Sell
-6,798
Closed -$310K 536
2016
Q2
$310K Buy
+6,798
New +$332K 0.15% 277
2016
Q1
Sell
-5,752
Closed -$231K 453
2015
Q4
$231K Buy
+5,752
New +$264K 0.18% 267

Other funds holding ENOV

Fox Run Management's ENOV Position: Q4 2025 in Review

Fox Run Management sold out of Enovis (ENOV) in Q4 2025, closing a stake of 22,104 shares — an estimated $671K sold.

Fox Run Management first reported a position in ENOV in Q4 2015 and held it in 11 quarters. The position peaked at $1.07M in Q1 2025. 254 funds tracked by Wall St. Rank hold ENOV as of Q4 2025.

  • Fox Run Management reported no remaining Enovis position as of Q4 2025 after selling out during the quarter.
  • Fox Run Management sold 22,104 Enovis shares in Q4 2025, an estimated $671K.
  • Fox Run Management first reported a position in Enovis in Q4 2015 and held it in 11 quarters.
  • Fox Run Management's Enovis position peaked at $1.07M in Q1 2025.
  • 254 funds tracked by Wall St. Rank held Enovis as of Q4 2025.

Based on Fox Run Management's 13F filing for Q4 2025, filed 11 Feb 2026.